• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why SOBR Safe Shares Surges Around 233%; Here Are 68 Biggest Movers From Yesterday

    9/21/22 3:04:01 AM ET
    $AMRS
    $ANVS
    $APGN
    $ARAV
    Major Chemicals
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AMRS alert in real time by email

    Gainers

    • SOBR Safe, Inc. (NASDAQ:SOBR) shares surged 232.8% to settle at $3.03 on Tuesday following a report suggesting The National Transportation Safety Board is recommending that NHTSA require passive alcohol-detection systems. The company is engaged in developing alcohol-detecting devices to address the automotive alcohol sensing spectrum.
    • Amprius Technologies, Inc. (NYSE:AMPX) shares jumped 86.4% to close at $11.00 on Tuesday.
    • Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) surged 60.6% to settle at $2.2005.
    • NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) gained 42.4% to close at $20.79. Strength may be due to short interest in the stock and social media interest.
    • Virax Biolabs Group Limited (NASDAQ:VRAX) climbed 41.3% to close at $3.49 after the company announced the distribution of a Monkeypox Virus Antigen Rapid Test Kits which has been launched in markets accepting the CE mark, such as the European Union.
    • Cassava Sciences, Inc. (NASDAQ:SAVA) gained 28.4% to close at $38.91.
    • TRxADE HEALTH, Inc. (NASDAQ:MEDS) gained 27.7% to close at $1.36 after the company announced Bonum Health, a subsidiary, signed a Telemedicine Services Distribution Deal with Wakefern Food, to deploy telemedicine services throughout ShopRite pharmacy-led locations in New Jersey, New York, Pennsylvania, Connecticut and Maryland.
    • Mobile Global Esports Inc. (NASDAQ:MGAM) shares climbed 26.5% to close at $3.06 after gaining over 4% on Monday.
    • SaverOne 2014 Ltd (NASDAQ:SVRE) rose 22.4% to close at $2.35. Strauss Frito-Lay chose the SaverOne Protection System for its delivery trucks in Israel.
    • Yunji Inc. (NASDAQ:YJ) gained 20.2% to close at $1.00.
    • bluebird bio, Inc. (NASDAQ:BLUE) jumped 15.7% to close at $6.86. Raymond James maintained bluebird bio with an Outperform and raised the price target from $8 to $10.
    • Renovacor, Inc. (NYSE:RCOR) jumped 14.7% to close at $2.18. Rocket Pharmaceuticals agreed to acquire Renovacor in an all-stock transaction for an implied value of approximately $2.60 per share.
    • Crown ElectroKinetics Corp. (NASDAQ:CRKN) shares gained 14.7% to close at $0.3753 on Tuesday. Crown ElectroKinetics, last month, posted a Q4 net loss of $4.5 million.
    • mCloud Technologies Corp. (NASDAQ:MCLD) rose 14.7% to settle at $2.1561.
    • Troika Media Group, Inc. (NASDAQ:TRKA) surged 14.4% to close at $0.46.
    • D-Wave Quantum Inc. (NYSE:QBTS) gained 14.3% to close at $6.56.
    • Mannatech, Incorporated (NASDAQ:MTEX) climbed 13.4% to settle at $19.85. Mannatech Board of Directors approved a share repurchase program to acquire up to $1.5 million of its outstanding shares.
    • China Liberal Education Holdings Limited (NASDAQ:CLEU) gained 13.3% to close at $0.9150. China Liberal Education Holdings recently signed a letter with Aiways Holdings Limited to acquire all outstanding equity interest of Aiways.
    • Reborn Coffee, Inc. (NASDAQ:REBN) jumped 11.9% to close at $2.26.
    • O2Micro International Limited (NASDAQ:OIIM) rose 11.2% to close at $3.28 after the company announced receipt of a revised preliminary non-binding proposal to acquire the company.
    • EuroDry Ltd. (NASDAQ:EDRY) gained 10.8% to settle at $14.43. The company signed an agreement to sell M/V Pantelis, a 74,020 dwt drybulk vessel, built in 2000, for approximately $9.7 million.
    • Dragon Victory International Limited (NASDAQ:LYL) gained 9.7% to settle at $0.8999.
    • Apexigen, Inc. (NASDAQ:APGN) gained 9.5% to close at $6.48. Apexigen recently announced the presentation of new data from a Phase 2 trial evaluating sotigalimab in combination with neoadjuvant chemoradiation for resectable esophageal and gastroesophageal junction cancers.
    • BTCS Inc. (NASDAQ:BTCS) rose 9.1% to settle at $1.56. BTCS, last month, posted a Q2 loss of $0.61 per share.
    • BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) shares rose 8.4% to close at $5.96. BYND Cannasoft shares jumped over 32% on Monday after the company announced it has signed a share purchase agreement to acquire 100% ownership of Zigi Carmel Initiatives & Investments for $28 million in stock.
    • SeqLL Inc. (NASDAQ:SQL) gained 7% to close at $0.86.
    • Cognex Corporation (NASDAQ:CGNX) rose 6.5% to close at $44.41 as the company boosted its guidance for the third quarter.
    • Change Healthcare Inc. (NASDAQ:CHNG) rose 6.4% to settle at $27.11 after a U.S. judge denied the Justice Department's request to stop UnitedHealth's $13 billion buyout deal for Change Healthcare.
    • Oxford Industries, Inc. (NYSE:OXM) climbed 5.9% to close at $95.32. Oxford Industries completed the acquisition of Johnny Was, a California-based affordable luxury apparel brand, for $270 million. Piper Sandler maintained Oxford Industries with an Overweight and raised the price target from $130 to $135.

     


    Losers

    • Virios Therapeutics, Inc. (NASDAQ:VIRI) shares dropped 75.5% to close at $0.49 on Tuesday after the company priced a 10 million share public offering at $0.50 per share. Also, HC Wainwright & Co downgraded the stock from Buy to Neutral.
    • Pagaya Technologies Ltd. (NASDAQ:PGY) shares fell 67.2% to close at $2.29 after dropping 11% on Monday.
    • Integrated Media Technology Limited (NASDAQ:IMTE) dropped 46.1% to close at $1.03.
    • Cosmos Holdings Inc. (NASDAQ:COSM) fell 39.1% to close at $0.2252.
    • Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) fell 37.5% to close at $0.6629 as the U.S. FDA staff raised concerns over the safety of the company’s experimental cancer drug and questioned the benefits it provided over existing therapies.
    • Tellurian Inc. (NYSE:TELL) fell 23.9% to close at $2.97.
    • CF Acquisition Corp. VI (NASDAQ:RUM) dipped 23.9% to close at $12.79.
    • PetVivo Holdings, Inc. (NASDAQ:PETV) dropped 22.5% to close at $1.93. PetVivo Holdings, last month, posted a Q1 loss of $0.20 per share.
    • HyreCar Inc. (NASDAQ:HYRE) fell 21.5% to close at $1.06. AmeriDrive partnered with HyreCar on $100 million revolving line of credit joint venture.
    • AMTD Digital Inc. (NYSE:HKD) dipped 21.2% to settle at $72.50.
    • Trevi Therapeutics, Inc. (NASDAQ:TRVI) dropped 19.9% to close at $2.45. Trevi Therapeutics recently announced results from the full set of subjects in its Phase 2 CANAL trial of Haduvio for treating chronic cough in idiopathic pulmonary fibrosis (IPF).
    • E-Home Household Service Holdings Limited (NASDAQ:EJH) fell 19.7% to close at $0.1245.
    • Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) dropped 19.2% to settle at $0.1810.
    • Swvl Holdings Corp. (NASDAQ:SWVL) fell 17.3% to close at $0.9350.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) dropped 16.9% to close at $18.61 following an FT report suggesting investors in the SPAC are pushing for better terms in a financing package.
    • Mynaric AG (NASDAQ:MYNA) fell 16.7% to close at $5.15.
    • Sotera Health Company (NASDAQ:SHC) fell 16.6% to close at $8.20.
    • Grove Collaborative Holdings, Inc. (NYSE:GROV) dropped 16.5% to close at $4.24.
    • Research Frontiers Incorporated (NASDAQ:REFR) declined 15.7% to settle at $2.37.
    • FOXO Technologies Inc. (NYSE:FOXO) fell 15.6% to close at $2.11.
    • Annovis Bio, Inc. (NASDAQ:ANVS) dropped 15% to settle at $15.87.
    • MicroCloud Hologram Inc (NASDAQ:HOLO) fell 13.9% to close at $2.54.
    • Montrose Environmental Group, Inc. (NYSE:MEG) dropped 13.9% to close at $36.91.
    • Weave Communications, Inc. (NYSE:WEAV) declined 13.6% to settle at $4.85.
    • Esports Entertainment Group, Inc. (NASDAQ:GMBL) fell 13.5% to settle at $0.1461. Esports Entertainment recently priced a 30 million share plus warrant public offering at $0.25 per share plus warrant.
    • Ventoux CCM Acquisition Corp. (NASDAQ:VTAQ) fell 13.3% to close at $6.11 after climbing around 55% on Monday.
    • Rockley Photonics Holdings Limited (NYSE:RKLY) dropped 12.8% to close at $0.9943.
    • Ford Motor Company (NYSE:F) fell 12.3% to close at $13.09 after the company previewed the effect of parts shortages on the company in the third-quarter and said inflation-related supplier costs during the third quarter will run about $1.0 billion higher than originally expected. The company also projects to have about 40,000 to 45,000 vehicles in inventory at end of third quarter lacking certain parts presently in short supply.
    • ReneSola Ltd (NYSE:SOL) tumbled 12% to settle at $5.35. Xianshou Li recently reported a 7.52% stake in ReneSola.
    • Arqit Quantum Inc. (NASDAQ:ARQQ) dropped 11.8% to close at $7.10.
    • Amyris, Inc. (NASDAQ:AMRS) fell 11.7% to close at $3.49.
    • Nurix Therapeutics, Inc. (NASDAQ:NRIX) dropped 11.6% to close at $13.07.
    • Gogoro Inc. (NASDAQ:GGR) fell 11.6% to settle at $4.65 after JP Morgan initiated coverage on the stock with an Underweight rating and a $4.30 price target.
    • Cipher Mining Inc. (NASDAQ:CIFR) dropped 9.8% to close at $1.47.
    • Vericity, Inc. (NASDAQ:VERY) fell 9.6% to close at $6.60.
    • AMC Entertainment Holdings, Inc. (NYSE:APE) declined 9.4% to close at $4.23.
    • Value Line, Inc. (NASDAQ:VALU) dropped 9.1% to close at $58.20. Value Line recently posted Q1 EPS of $0.47.
    • Clovis Oncology, Inc. (NASDAQ:CLVS) fell 8.9% to close at $1.12. Clovis Oncology recently submitted applications for Rubraca label expansion in the US and European Union as first-line maintenance treatment in women with advanced ovarian cancer.
    • Aravive, Inc. (NASDAQ:ARAV) fell 8.6% to settle at $0.9320.
    Get the next $AMRS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMRS
    $ANVS
    $APGN
    $ARAV

    CompanyDatePrice TargetRatingAnalyst
    Cognex Corporation
    $CGNX
    2/17/2026$68.00Hold → Buy
    HSBC Securities
    EuroDry Ltd.
    $EDRY
    2/12/2026$23.50Market Perform → Outperform
    Noble Capital Markets
    D-Wave Quantum Inc.
    $QBTS
    2/12/2026Buy
    TD Cowen
    Cipher Mining Inc.
    $CIFR
    2/9/2026$38.00Overweight
    Morgan Stanley
    Oxford Industries Inc.
    $OXM
    1/13/2026$35.00 → $40.00Market Perform
    Telsey Advisory Group
    Sotera Health Company
    $SHC
    1/9/2026$24.00Neutral → Overweight
    Piper Sandler
    Sotera Health Company
    $SHC
    1/9/2026$24.00Outperform
    RBC Capital Mkts
    Nurix Therapeutics Inc.
    $NRIX
    1/8/2026$36.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $AMRS
    $ANVS
    $APGN
    $ARAV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Siokas Grigorios bought $145,000 worth of shares (388,532 units at $0.37), increasing direct ownership by 5% to 8,861,914 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/13/26 10:05:37 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Siokas Grigorios bought $120,000 worth of shares (291,262 units at $0.41), increasing direct ownership by 4% to 8,473,382 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/12/26 2:20:08 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Siokas Grigorios bought $45,000 worth of shares (90,325 units at $0.50), increasing direct ownership by 1% to 8,182,120 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    1/26/26 11:48:12 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    $AMRS
    $ANVS
    $APGN
    $ARAV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cognex upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded Cognex from Hold to Buy and set a new price target of $68.00

    2/17/26 8:01:33 AM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    EuroDry upgraded by Noble Capital Markets with a new price target

    Noble Capital Markets upgraded EuroDry from Market Perform to Outperform and set a new price target of $23.50

    2/12/26 9:28:12 AM ET
    $EDRY
    Marine Transportation
    Consumer Discretionary

    TD Cowen initiated coverage on D-Wave Quantum

    TD Cowen initiated coverage of D-Wave Quantum with a rating of Buy

    2/12/26 7:24:12 AM ET
    $QBTS
    EDP Services
    Technology

    $AMRS
    $ANVS
    $APGN
    $ARAV
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-13) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 12/21/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    12/22/22 4:37:40 AM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    August 17, 2022 - FDA Approves First Cell-Based Gene Therapy to Treat Adult and Pediatric Patients with Beta-thalassemia Who Require Regular Blood Transfusions

    For Immediate Release: August 17, 2022 Today, the U.S. Food and Drug Administration approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions.  “Today’s approval is an important advance in the treatment of beta-thalassemia, particularly in individuals who require ongoing

    8/17/22 2:12:27 PM ET
    $BLUE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AMRS
    $ANVS
    $APGN
    $ARAV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Parrotte Dianne M converted options into 8,324 shares, increasing direct ownership by 38% to 30,518 units (SEC Form 4)

    4 - COGNEX CORP (0000851205) (Issuer)

    2/19/26 5:02:11 PM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    CEO & President Moschner Matthew converted options into 5,085 shares and covered exercise/tax liability with 1,600 shares, increasing direct ownership by 42% to 11,847 units (SEC Form 4)

    4 - COGNEX CORP (0000851205) (Issuer)

    2/19/26 4:59:29 PM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    SVP, Chief Financial Officer Fehr Dennis converted options into 5,085 shares and covered exercise/tax liability with 1,618 shares, increasing direct ownership by 38% to 12,578 units (SEC Form 4)

    4 - COGNEX CORP (0000851205) (Issuer)

    2/19/26 4:56:26 PM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    $AMRS
    $ANVS
    $APGN
    $ARAV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Grove to Report Fourth Quarter and Full Year 2025 Financial Results on March 5, 2026

    Grove Collaborative Holdings, Inc. (NYSE:GROV) ("Grove" or "the Company"), the world's first plastic-neutral retailer and a leading sustainable consumer products company, certified B Corporation, and Public Benefit Corporation today announced that it will report fourth quarter and full year 2025 financial results after the market closes on Thursday, March 5, 2026. The Company will host an investor conference call and webcast to review these financial results at 5:00pm ET / 2:00pm PT on the same day. The webcast can be accessed at https://investors.grove.co/. The conference call can be accessed by calling 877-413-7205. International callers may dial +1 201-689-8537. A replay of the call wi

    2/19/26 4:05:00 PM ET
    $GROV
    Catalog/Specialty Distribution
    Consumer Discretionary

    Weave Announces Fourth Quarter and Full Year 2025 Financial Results

    Fourth quarter total revenue of $63.4 million, up 17.0% year over year Full year total revenue of $239.0 million, up 17.0% year over year Fourth quarter GAAP gross margin of 72.7%, up 60 basis points year over year Full year GAAP gross margin of 72.1%, up 70 basis points year over year Fourth quarter Non-GAAP gross margin of 73.3%, up 70 basis points year over year Full year Non-GAAP gross margin of 72.7%, up 80 basis points year over year Full year net cash provided by operating activities was $17.5 million, up $3.4 million year over year Full year free cash flow was $12.9 million, up $2.5 million year over year Weave Communications, Inc. ("Weave") (NYSE:WEAV), a l

    2/19/26 4:05:00 PM ET
    $SYF
    $WEAV
    Finance: Consumer Services
    Finance
    Computer Software: Prepackaged Software
    Technology

    EuroDry Ltd. Reports Results for the Quarter and Year Ended December 31, 2025

    ATHENS, Greece, Feb. 19, 2026 (GLOBE NEWSWIRE) -- EuroDry Ltd. (NASDAQ:EDRY, the "Company" or "EuroDry")), an owner and operator of drybulk vessels and provider of seaborne transportation for drybulk cargoes, announced today its results for the three and twelve-month periods ended December 31, 2025.   Fourth Quarter 2025 Highlights: Total net revenues of $17.4 million.Net income attributable to controlling shareholders, of $3.2 million or $1.14 earnings per share attributable to controlling shareholders basic and diluted.Adjusted net income1 attributable to controlling shareholders, for the quarter of $2.4 million, or, $0.88 and $0.87 per share attributable to controlling shareholders ba

    2/19/26 4:05:00 PM ET
    $EDRY
    Marine Transportation
    Consumer Discretionary

    $AMRS
    $ANVS
    $APGN
    $ARAV
    SEC Filings

    View All

    Amendment: Cognex Corporation filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    8-K/A - COGNEX CORP (0000851205) (Filer)

    2/19/26 4:06:11 PM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    Weave Communications Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Weave Communications, Inc. (0001609151) (Filer)

    2/19/26 4:01:53 PM ET
    $WEAV
    Computer Software: Prepackaged Software
    Technology

    Cassava Sciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - CASSAVA SCIENCES INC (0001069530) (Filer)

    2/19/26 8:15:27 AM ET
    $SAVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMRS
    $ANVS
    $APGN
    $ARAV
    Financials

    Live finance-specific insights

    View All

    Grove to Report Fourth Quarter and Full Year 2025 Financial Results on March 5, 2026

    Grove Collaborative Holdings, Inc. (NYSE:GROV) ("Grove" or "the Company"), the world's first plastic-neutral retailer and a leading sustainable consumer products company, certified B Corporation, and Public Benefit Corporation today announced that it will report fourth quarter and full year 2025 financial results after the market closes on Thursday, March 5, 2026. The Company will host an investor conference call and webcast to review these financial results at 5:00pm ET / 2:00pm PT on the same day. The webcast can be accessed at https://investors.grove.co/. The conference call can be accessed by calling 877-413-7205. International callers may dial +1 201-689-8537. A replay of the call wi

    2/19/26 4:05:00 PM ET
    $GROV
    Catalog/Specialty Distribution
    Consumer Discretionary

    Weave Announces Fourth Quarter and Full Year 2025 Financial Results

    Fourth quarter total revenue of $63.4 million, up 17.0% year over year Full year total revenue of $239.0 million, up 17.0% year over year Fourth quarter GAAP gross margin of 72.7%, up 60 basis points year over year Full year GAAP gross margin of 72.1%, up 70 basis points year over year Fourth quarter Non-GAAP gross margin of 73.3%, up 70 basis points year over year Full year Non-GAAP gross margin of 72.7%, up 80 basis points year over year Full year net cash provided by operating activities was $17.5 million, up $3.4 million year over year Full year free cash flow was $12.9 million, up $2.5 million year over year Weave Communications, Inc. ("Weave") (NYSE:WEAV), a l

    2/19/26 4:05:00 PM ET
    $SYF
    $WEAV
    Finance: Consumer Services
    Finance
    Computer Software: Prepackaged Software
    Technology

    EuroDry Ltd. Reports Results for the Quarter and Year Ended December 31, 2025

    ATHENS, Greece, Feb. 19, 2026 (GLOBE NEWSWIRE) -- EuroDry Ltd. (NASDAQ:EDRY, the "Company" or "EuroDry")), an owner and operator of drybulk vessels and provider of seaborne transportation for drybulk cargoes, announced today its results for the three and twelve-month periods ended December 31, 2025.   Fourth Quarter 2025 Highlights: Total net revenues of $17.4 million.Net income attributable to controlling shareholders, of $3.2 million or $1.14 earnings per share attributable to controlling shareholders basic and diluted.Adjusted net income1 attributable to controlling shareholders, for the quarter of $2.4 million, or, $0.88 and $0.87 per share attributable to controlling shareholders ba

    2/19/26 4:05:00 PM ET
    $EDRY
    Marine Transportation
    Consumer Discretionary

    $AMRS
    $ANVS
    $APGN
    $ARAV
    Leadership Updates

    Live Leadership Updates

    View All

    D-Wave Joins Southeastern Quantum Collaborative as Inaugural Member

    D-Wave Quantum Inc. (NYSE:QBTS) ("D-Wave" or the "Company"), the only dual-platform quantum computing company, providing both annealing and gate-model systems, software and services, today joined the Southeastern Quantum Collaborative (SQC) as an inaugural member, along with The University of Alabama in Huntsville, Davidson Technologies, IBM and Alabama A&M University. The SQC will bring together academia, industry and government to accelerate the advancement and application of quantum information science and technology across the Southeast. In addition, it aims to develop the quantum-ready workforce needed to commercialize the technology. Given Davidson hosts a D-Wave Advantage2TM system

    2/19/26 7:00:00 AM ET
    $QBTS
    EDP Services
    Technology

    Cognex Appoints Sami Atiya and Chris Donato to Board of Directors

    NATICK, Mass., Feb. 17, 2026 /PRNewswire/ -- Cognex Corporation (NASDAQ:CGNX), ("Cognex"), the global technology leader in industrial machine vision, today announced the appointments of Dr. Sami Atiya and Mr. Chris Donato to Cognex's Board of Directors (the "Board"), effective March 2, 2026.  "We are excited to welcome Sami and Chris to our Board," said Matt Moschner, President and CEO. "We remain focused on our strategic objectives of becoming the leading provider of AI technology for industrial machine vision, delivering the best customer experience in our industry and doublin

    2/17/26 8:00:00 AM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    Cipher Welcomes Thomas Duda to the Company's Board of Directors

    NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ:CIFR) ("Cipher" or the "Company"), a leading developer and operator of industrial-scale data centers, today announces the appointment of Thomas Duda to its Board of Directors. Mr. Duda has more than twenty years of real estate-focused investment experience, further strengthening the Board as Cipher executes its pivot to becoming a world leader in data center development and operations. Mr. Duda currently serves as Vice President of Real Estate at Henry Crown and Company, where he leads the firm's real estate investment and asset management activities, and is a member of the Investment and Management Committee. Previous

    2/11/26 4:05:00 PM ET
    $CIFR
    Finance: Consumer Services
    Finance

    $AMRS
    $ANVS
    $APGN
    $ARAV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Montrose Environmental Group Inc.

    SC 13G - Montrose Environmental Group, Inc. (0001643615) (Subject)

    12/17/24 4:20:32 PM ET
    $MEG
    Professional Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Arqit Quantum Inc.

    SC 13D/A - Arqit Quantum Inc. (0001859690) (Subject)

    12/13/24 8:03:28 PM ET
    $ARQQ
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Arqit Quantum Inc.

    SC 13D/A - Arqit Quantum Inc. (0001859690) (Subject)

    12/10/24 8:05:26 PM ET
    $ARQQ
    Computer Software: Prepackaged Software
    Technology